| Dr Richard C Allen, MD | |
|
3705 Medical Pkwy Ste 120, Austin, TX 78705-1022 | |
| (512) 458-2141 | |
| (512) 458-4824 |
| Full Name | Dr Richard C Allen |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 29 Years |
| Location | 3705 Medical Pkwy Ste 120, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104827351 | NPI | - | NPPES |
| P00323169 | Other | NM | MEDICARE ID |
| 117117504 (MDACC) | Medicaid | TX | |
| 708050 | Medicaid | AZ | |
| NM001H54 | Other | NM | BC BS OF NM |
| 85104272 | Medicaid | NM |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Regional Health Center | Bryan, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oculoplastic Consultants Llp | 3173594249 | 11 |
| Physicians Referral Service | 7911801410 | 2364 |
News Archive
Pfizer Inc. announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) on its New Drug Application (NDA) for tafamidis meglumine.
Combining the latest methods in gene splicing and computer modeling, Rice University researchers are trying to develop a predictive framework for one of the most basic and complex biological phenomena — cellular heterogeneity, or the ability of genetic clones to act and behave differently when exposed to the same set of environmental stimuli.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the MADRS scale.
Hasbro Children's Hospital emergency medicine physician James Linakis, M.D., Ph.D, was recently awarded a five-year, $3.2 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at the National Institutes of Health (NIH) to validate a more efficient test to screen teenagers for future alcohol abuse and other risk behaviors.
› Verified 2 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
Pfizer Inc. announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) on its New Drug Application (NDA) for tafamidis meglumine.
Combining the latest methods in gene splicing and computer modeling, Rice University researchers are trying to develop a predictive framework for one of the most basic and complex biological phenomena — cellular heterogeneity, or the ability of genetic clones to act and behave differently when exposed to the same set of environmental stimuli.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the MADRS scale.
Hasbro Children's Hospital emergency medicine physician James Linakis, M.D., Ph.D, was recently awarded a five-year, $3.2 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at the National Institutes of Health (NIH) to validate a more efficient test to screen teenagers for future alcohol abuse and other risk behaviors.
› Verified 2 days ago
| Entity Name | Physicians Referral Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073574810 PECOS PAC ID: 7911801410 Enrollment ID: O20031125000953 |
News Archive
Pfizer Inc. announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) on its New Drug Application (NDA) for tafamidis meglumine.
Combining the latest methods in gene splicing and computer modeling, Rice University researchers are trying to develop a predictive framework for one of the most basic and complex biological phenomena — cellular heterogeneity, or the ability of genetic clones to act and behave differently when exposed to the same set of environmental stimuli.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the MADRS scale.
Hasbro Children's Hospital emergency medicine physician James Linakis, M.D., Ph.D, was recently awarded a five-year, $3.2 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at the National Institutes of Health (NIH) to validate a more efficient test to screen teenagers for future alcohol abuse and other risk behaviors.
› Verified 2 days ago
| Entity Name | Texas Oculoplastic Consultants Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942270103 PECOS PAC ID: 3173594249 Enrollment ID: O20040803000574 |
News Archive
Pfizer Inc. announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) on its New Drug Application (NDA) for tafamidis meglumine.
Combining the latest methods in gene splicing and computer modeling, Rice University researchers are trying to develop a predictive framework for one of the most basic and complex biological phenomena — cellular heterogeneity, or the ability of genetic clones to act and behave differently when exposed to the same set of environmental stimuli.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the MADRS scale.
Hasbro Children's Hospital emergency medicine physician James Linakis, M.D., Ph.D, was recently awarded a five-year, $3.2 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at the National Institutes of Health (NIH) to validate a more efficient test to screen teenagers for future alcohol abuse and other risk behaviors.
› Verified 2 days ago
| Entity Name | Texas Childrens Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861675506 PECOS PAC ID: 4385722081 Enrollment ID: O20080422000209 |
News Archive
Pfizer Inc. announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) on its New Drug Application (NDA) for tafamidis meglumine.
Combining the latest methods in gene splicing and computer modeling, Rice University researchers are trying to develop a predictive framework for one of the most basic and complex biological phenomena — cellular heterogeneity, or the ability of genetic clones to act and behave differently when exposed to the same set of environmental stimuli.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the MADRS scale.
Hasbro Children's Hospital emergency medicine physician James Linakis, M.D., Ph.D, was recently awarded a five-year, $3.2 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at the National Institutes of Health (NIH) to validate a more efficient test to screen teenagers for future alcohol abuse and other risk behaviors.
› Verified 2 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
Pfizer Inc. announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) on its New Drug Application (NDA) for tafamidis meglumine.
Combining the latest methods in gene splicing and computer modeling, Rice University researchers are trying to develop a predictive framework for one of the most basic and complex biological phenomena — cellular heterogeneity, or the ability of genetic clones to act and behave differently when exposed to the same set of environmental stimuli.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the MADRS scale.
Hasbro Children's Hospital emergency medicine physician James Linakis, M.D., Ph.D, was recently awarded a five-year, $3.2 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at the National Institutes of Health (NIH) to validate a more efficient test to screen teenagers for future alcohol abuse and other risk behaviors.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard C Allen, MD 3705 Medical Pkwy Ste 120, Austin, TX 78705-1022 Ph: (512) 458-2141 | Dr Richard C Allen, MD 3705 Medical Pkwy Ste 120, Austin, TX 78705-1022 Ph: (512) 458-2141 |
News Archive
Pfizer Inc. announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) on its New Drug Application (NDA) for tafamidis meglumine.
Combining the latest methods in gene splicing and computer modeling, Rice University researchers are trying to develop a predictive framework for one of the most basic and complex biological phenomena — cellular heterogeneity, or the ability of genetic clones to act and behave differently when exposed to the same set of environmental stimuli.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
In the largest randomized, double-blind, placebo controlled study to date on the effect of OnabotulinumtoxinA (as known as Botox) on depression, researchers found that more than half of subjects suffering from moderate to severe depression showed a substantial improvement (greater than or equal to 50% of baseline) in their depressive symptoms as measured by the MADRS scale.
Hasbro Children's Hospital emergency medicine physician James Linakis, M.D., Ph.D, was recently awarded a five-year, $3.2 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at the National Institutes of Health (NIH) to validate a more efficient test to screen teenagers for future alcohol abuse and other risk behaviors.
› Verified 2 days ago
Dr. Kristen Michelle Hawthorne, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Saradha Chexal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy Ste 460, Austin, TX 78705 Phone: 512-454-5851 | |
Dr. John David Fisher, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2901 Montopolis Dr, Austin, TX 78741 Phone: 512-389-6571 Fax: 512-389-6511 | |
Dr. Clio Armitage Harper Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 W 38th St, Suite 200, Austin, TX 78705 Phone: 512-451-0103 Fax: 512-451-2741 | |
Dr. Nadja Ivette Torres, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Fuad Makkouk, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9707 Anderson Mill Rd Ste 230, Austin, TX 78750 Phone: 512-693-9363 | |
Irina Volosko, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3410 Far West Blvd Ste 140, Austin, TX 78731 Phone: 512-427-1107 Fax: 512-427-1207 |